Anlotinib
CAS: 1058156-90-3
Ref. 3D-ISB15690
| 1g | 8,386.00 € | ||
| 50mg | 977.00 € | ||
| 100mg | 1,493.00 € | ||
| 250mg | 3,561.00 € | ||
| 500mg | 5,703.00 € |
Product Information
Anlotinib is a drug that belongs to the class of small-molecule tyrosine kinase inhibitors and is currently being investigated for the treatment of various cancers. It inhibits signal transduction by binding to tyrosine kinases, which are enzymes that regulate a wide variety of cellular functions. The molecular docking analysis revealed that Anlotinib binds to the ATP binding site on multidrug resistance protein 1 (MRP1). This molecule also inhibits cell factor, matrix effect, and liver lesions in mice. Anlotinib has been shown to inhibit squamous carcinoma in humans with lung cancer, as well as eye disorders such as age-related macular degeneration. It also has potential as a biomarker for α1-acid glycoprotein levels in human serum.
Chemical properties
Technical inquiry about: 3D-ISB15690 Anlotinib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
